Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4638 USD | +0.83% | +2.77% | -33.84% |
10/05 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
558M | - | - | - | - | - | |
125B | ||||||
108B | ||||||
24.57B | - | |||||
22.82B | - | |||||
18.19B |